Literature DB >> 8089046

Significant reduction in chloroquine bioavailability following coadministration with the Sudanese beverages Aradaib, Karkadi and Lemon.

B M Mahmoud1, H M Ali, M M Homeida, J L Bennett.   

Abstract

Chloroquine bioavailability in healthy males was examined following oral coadministration of 600 mg with three common Sudanese beverages, Aradaib (Tamarindus indica), Karkadi (Hibiscus sabdarifa) and Lemon (Citrus limetta) and drinking water. The tablets and beverages were taken on an empty stomach after an overnight fast. The plasma chloroquine concentrations were measured by HPLC. The extent and rate of chloroquine bioavailability were described by the area under the plasma concentrations versus time curve (AUC), the peak plasma concentration (Cmax) and with the time to reach Cmax (Tmax), respectively. The mean (+/- S.E.) AUC values after administration with water (control) and Aradaib, Karkadi and Lemon, respectively, were 7.52 +/- 0.87, 2.60 +/- 0.24, 2.16 +/- 0.30 and 2.41 +/- 0.29 mg.h/L. The corresponding mean Cmax values were 553 +/- 17.8, 184 +/- 21.3, 148 +/- 14.1 and 210 +/- 17.4 mg/L and the corresponding Tmax values were 3.0 +/- 1.0, 3.2 +/- 1.2, 2.6 +/- 0.8 and 2.5 +/- 1.0 h. The results indicate a statistically significant reduction in the AUC and Cmax of chloroquine as a result of a coadministration with each of the three beverages. A parallel reduction in the drugs antimalarial efficacy might be expected.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8089046     DOI: 10.1093/jac/33.5.1005

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Self-medication practices in Khartoum State, Sudan.

Authors:  Abdelmoneim Ismail Awad; Idris Babiker Eltayeb; Phillip A Capps
Journal:  Eur J Clin Pharmacol       Date:  2006-03-07       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.

Authors:  J Ducharme; R Farinotti
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

Review 3.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

4.  Protection from anthrax toxin-mediated killing of macrophages by the combined effects of furin inhibitors and chloroquine.

Authors:  Tomoko Komiyama; Joel A Swanson; Robert S Fuller
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

5.  In vitro inhibitory activities of the extract of Hibiscus sabdariffa L. (family Malvaceae) on selected cytochrome P450 isoforms.

Authors:  Showande Segun Johnson; Fakeye Titilayo Oyelola; Tolonen Ari; Hokkanen Juho
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-04-12

6.  Effect of Khat (Catha edulis) Use on the Bioavailability, Plasma Levels and Antimalarial Activity of Chloroquine.

Authors:  Faiza H Issa; Molhem Al-Habori; Michael L Chance
Journal:  Sultan Qaboos Univ Med J       Date:  2016-05-15

7.  In vitro vasorelaxation mechanisms of bioactive compounds extracted from Hibiscus sabdariffa on rat thoracic aorta.

Authors:  Mamadou Sarr; Saliou Ngom; Modou O Kane; Alassane Wele; Doudou Diop; Bocar Sarr; Lamine Gueye; Ramaroson Andriantsitohaina; Aminata S Diallo
Journal:  Nutr Metab (Lond)       Date:  2009-11-02       Impact factor: 4.169

Review 8.  Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection.

Authors:  Melanie R Nicol; Abhay Joshi; Matthew L Rizk; Philip E Sabato; Radojka M Savic; David Wesche; Jenny H Zheng; Jack Cook
Journal:  Clin Pharmacol Ther       Date:  2020-09-01       Impact factor: 6.903

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.